Macrophage migration inhibitory factor and DJ-1 in gastric cancer: Differences between high-incidence and low-incidence areas

British Journal of Cancer

Volumn 107, Issue 9, 2012, Pages 1595-1601

  Shimwell, N J ^a   Ward, D G ^a   Mohri, Y ^b   Mohri, T ^c   Pallan, L ^a   Teng, M ^a   Miki, Y C ^b   Kusunoki, M ^b   Tucker, O ^a   Wei, W ^a   Morse, J ^a   Johnson, P J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MIE UNIVERSITY   (Japan)

^c Toyama Hospital   (Japan)

Author keywords

DJ 1; gastric cancer; geographical differences; MIF

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; DJ 1; IMMUNOGLOBULIN G; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; JAPAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; UNITED KINGDOM;

COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; ONCOGENE PROTEINS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84867894220     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.405     Document Type: Article

References (49)

1. Alberts SR, Cervantes A, van de Velde CJ (2003) Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14(Suppl 2): ii31-ii36
2. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15: 2281-2290
3. Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G, Heutink P (2003) DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24: 159-160
4. Camlica H, Duranyildiz D, Oguz H, Oral EN, Yasasever V (2008) The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer. Pathol Oncol Res 14: 79-83
5. Cao M, Yie S, Liu J, Ye S, Xia D, Gao E (2011) Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigen 78: 120-128
6. Chevinsky AH (1991) CEA in tumors of other than colorectal origin. Semin Surg Oncol 7: 162-166
7. Chong P, Lee H, Loh M, Choong L, Lin Q, So J, Lim K, Soo R, Yong W, Chan S, Smoot D, Ashktorab H, Yeoh K, Lim Y (2010) Upregulation of plasma C9 protein in gastric cancer patients. Proteomics 10: 3210-3221
8. Cohen M, Yossef R, Erez T, Kugel A, Welt M, Karpasas M, Bones J, Rudd P, Taieb J, Boissin H, Harats D, Noy K, Tekoah Y, Lichtenstein R, Rubin E, Porgador A (2011) Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One 6: e14540
9. Ebert MP, Kruger S, Fogeron ML, Lamer S, Chen J, Pross M, Schulz HU, Lage H, Heim S, Roessner A, Malfertheiner P, Rocken C (2005a) Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics 5: 1693-1704
10. Ebert MP, Lamer S, Meuer J, Malfertheiner P, Reymond M, Buschmann T, Rocken C, Seibert V (2005b) Identification of the thrombin light chain a as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis. J Proteome Res 4: 586-590
11. Ebert MP, Niemeyer D, Deininger SO, Wex T, Knippig C, Hoffmann J, Sauer J, Albrecht W, Malfertheiner P, Rocken C (2006) Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J Proteome Res 5: 2152-2158
12. Fletcher RH (1986) Carcinoembryonic antigen. Ann Intern Med 104: 66-73
13. Gomceli I, Bostanci E, Ozer I, Kemik A, Turhan N, Tez M, Kilic S, Demiriz B, Akoglu M (2012) A novel screening biomarker in gastric cancer: serum dickkopf-1. Hepatogastroenterology 59: 1661-1664
14. Guo JF, Xiao B, Liao B, Zhang XW, Nie LL, Zhang YH, Shen L, Jiang H, Xia K, Pan Q, Yan XX, Tang BS (2008) Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism. Mov Disord 23: 2074-2079
15. He XX, Yang J, Ding YW, Liu W, Shen QY, Xia HH (2006) Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut 55: 797-802
16. Hsu P, Chen C, Hsieh C, Chang W, Lai K, Lo G, Hsu P, Tsay F, Chen Y, Hsiao M, Chen H, Lu P (2007) Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin Cancer Res 13: 876-883
17. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T (2001) Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 32: 41-44
18. Japanese Gastric Cancer A (1998) Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1: 10-24
19. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66
20. Jung H, Seong HA, Ha H (2008) Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 283: 20383-20396
21. Kim H, Reyzer M, Choi I, Kim C, Kim H, Oshima A, Chertov O, Colantonio S, Fisher R, Allen J, Caprioli R, Green J (2010) Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res 9: 4123-4130
22. Kobayashi Y, Niwa Y, Tajika M, Kawai H, Kondo S, Hara K, Mizuno N, Hijioka S, Sawaki A, Matsuo K, Nakagawa H, Nakamura Y, Yamao K (2010) Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer. Hepatogastroenterology 57: 1631-1634
23. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H, Morimura R, Nagata H, Arita T, Kawaguchi T, Hirashima S, Fujiwara H, Okamoto K, Otsuji E (2012) Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre-and postoperative plasma. Br J Cancer 106: 740-747
24. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S, Hanash SM (2001) Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7: 3328-3335
25. Lebiedz P, Heidemann J, Lugering A, Riedel S, Herbst H, Domschke W, Kucharzik T, Maaser C (2006) Gastric epithelial expression of macrophage migration inhibitory factor is not altered by Helicobacter pylori infection in humans. Helicobacter 11: 258-265
26. Li GQ, Xie J, Lei XY, Zhang L (2009) Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol 15: 5541-5548
27. Mo J, Jung J, Yoon J, Hong J, Kim M, Ann E, Seo M, Choi Y, Park H (2010) DJ-1 modulates the p38 mitogen-activated protein kinase pathway through physical interaction with apoptosis signal-regulating kinase 1. J Cell Biochem 110: 229-237
28. Mohri Y, Mohri T, Wei W, Qi YJ, Martin A, Miki C, Kusunoki M, Ward DG, Johnson PJ (2009) Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Br J Cancer 101: 295-302
29. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509-513
30. Ossandon F, Villarroel C, Aguayo F, Santibanez E, Oue N, Yasui W, Corvalan A (2008) In silico analysis of gastric carcinoma Serial Analysis of Gene Expression libraries reveals different profiles associated with ethnicity. Mol Cancer 7: 1-9
31. Polanski M, Anderson NL (2007) A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 1: 1-48
32. Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, Chen Y, Jiang G, Lau C, Yu WC, Bacher M, Fan ST (2003) Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107: 22-29
33. Royston P, Altman D (1994) Regression using fractional polynomials of continuous covariates. Appl Stat 3: 429-467
34. Shun CT, Lin JT, Huang SP, Lin MT, Wu MS (2005) Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol 11: 3767-3771
35. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85: 1457-1459
36. Song M, Pan K, Su H, Zhang L, Ma J, Li J, Yuasa Y, Kang D, Kim Y, You W (2012) Identification of serum microRNAs as novel noninvasive biomarkers for early detection of gastric cancer. PLoS One 7: e33608
37. Steinberg WM, Gelfand R, Anderson KK, Glenn J, Kurtzman SH, Sindelar WF, Toskes PP (1986) Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 90: 343-349
38. Taira T, Saito Y, Niki T, Iguchi-Ariga S, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218
39. Theuer C, Campbell B, Peel D, Lin F, Carpenter P, Ziogas A, Butler J (2002) Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 137: 960-965
40. Tian M, Cui YZ, Song GH, Zong MJ, Zhou XY, Chen Y, Han JX (2008) Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 8: 241
41. Triantafillidis JK, Merikas E, Govosdis V, Konstandellou E, Cheracakis P, Barbatzas C, Tzourmakliotis D, Peros G (2003) Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer. Hepatogastroenterology 50(Suppl 2): cclvi-cclx
42. Tsuchiya B, Iwaya K, Kohno N, Kawate T, Akahoshi T, Matsubara O, Mukai K (2012) Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast. Histopathology 61: 69-77
43. Vasseur S, Afzal S, Tardivel-Lacombe J, Park DS, Iovanna JL, Mak TW (2009) DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci USA 106: 1111-1116
44. Vasseur S, Afzal S, Tomasini R, Guillaumond F, Tardivel-Lacombe J, Mak T, Iovanna J (2012) Consequences of DJ-1 upregulation following p53 loss and cell transformation. Oncogene 31: 664-670
45. Wu W, Juan W, Liang C, Yeoh K, So J, Chung M (2012) S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl 6: 152-162
46. Xia HH, Lam SK, Chan AO, Lin MC, Kung HF, Ogura K, Berg DE, Wong BC (2005) Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells. World J Gastroenterol 11: 1946-1950
47. Xia HH, Yang Y, Chu KM, Gu Q, Zhang YY, He H, Wong WM, Leung SY, Yuen ST, Yuen MF, Chan AO, Wong BC (2009) Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer 115: 5441-5449
48. Yamashita K, Sakuramoto S, Watanabe M (2011) Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today 41: 24-38
49. Zheng Y, Chen L, Li J, Yu B, Su L, Chen X, Yu Y, Yan M, Liu B, Zhu Z (2011) Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis. Clin Biochem 44: 1405-1411